Biolase inc.

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2023, and to answer questions. To access the live call, dial 1-866-682-6100 (U.S.) or +1 862-298-0702 (International) and ask to join the BIOLASE call.22 jul 2018 ... La compañía americana BIOLASE, INC ubicada en Irvine (California) ha dedicado más de 30 años no solo a fabricar y comercializar los diferentes ...BIOLASE, Inc. (NASDAQ:BIOL) issued its quarterly earnings data on Thursday, November, 9th. The medical technology company reported ($3.89) EPS for the quarter. The medical technology company earned $10.92 million during the quarter. BIOLASE had a negative trailing twelve-month return on equity of 503.34% and a negative net margin of 50.61%. 150 Royall St. Suite V. Canton MA 02021. Under the rights offering, BIOLASE will distribute one non-transferable subscription right for each share of common stock and each warrant issued in a private placement transaction that was consummated on June 10, 2020 (on an as-if-converted-to-common-stock basis) held on the Record Date (July 1, 2020).BIOLASE's Board of Directors unanimously recommends that stockholders vote "FOR" the amendment to the BIOLASE, Inc. Certificate of Incorporation to effect a reverse stock split (without reducing the authorized number of shares of common stock). The text of the letter is as follows: ***** October 27, 2021. Dear Fellow Stockholders:

Sep 14, 2023 · BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit is $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.

Find international BIOLASE distributors in Italy, Russia, Bulgaria, Spain, Spain, France, Poland, Germany, Ukraine, UK, Greece, and elsewhere.

Payment processing is an ever-evolving field. Here is how NationalLink, Inc. has evolved to provide payment solutions to banks, businesses. Payment processing is an ever-evolving field. And NationalLink, Inc. has evolved with it over the pa...LAKE FOREST, Calif., June 13, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that due to growing demand for its market leading laser technology, BIOLASE is producing a podcast series aimed at discussing cutting-edge protocols, technologies, and approaches to improving …Hayward Pool Products Inc has been a leader in the swimming pool industry for over 90 years. Founded in 1925, Hayward has been committed to providing innovative and high-quality products for residential and commercial pools.Biolase, Inc To Report Second Quarter 2022 Results On August 11, 2022. Jul 28, 2022. Report incorrect company information. Blogs. Elevating Endodontics with Dental Lasers. Jan 19, 2023. Waterlase Exclusive Trial Program: A Seamless Integration of Patient-Friendly Laser Technology.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2023.

Feb 6, 2021 · BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies ...

BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including digital x …BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit is $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and ...Aug 11, 2022 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2022, and to answer questions. To access the live call, dial 1-877-545-0320 (U.S.) or +1 973-528-0002 (International) and provide the following code: 838343. BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed ...

LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable …BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the...Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software.BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all ... BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies ...

Dec 1, 2023 · Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental ... BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC...

LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's stockholders granted the Board of Directors the discretion to effect a reverse …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…May 26, 2023 · LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a ... 1997. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental ...Biolase, Inc. Enters into the Eleventh Amendment to Credit Agreement with SWK Funding LLC CI Nov. 09: BIOLASE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CIDentists & Laser Dentistry. BIOLASE dental laser technology is designed expressly for dental applications, such as cavity preparations, soft tissue surgeries, and much more. Learn why Waterlase is the essential dental laser solution for your practice. LEARN MORE.

View and filter SEC Filings by group or type. Annual Reports Quarterly Reports View All. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….

Apr 20, 2021 · BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

Get the latest BIOLASE Inc (BIOL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and …Nov 10, 2021 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada ... BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2023, and to answer questions. To access the live ...BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is 800 …Feb 27, 2023 · BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive… Biolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ...BIOLASE Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. BIOLASE Inc’s trailing 12-month revenue is $49.7 million with a -50.6% profit margin. Year-over-year quarterly sales growth most recently was -9.2%. Analysts expect adjusted earnings to reach $-26.145 per share for the current fiscal year.

BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…View the latest Biolase Inc. (BIOL) stock price, news, historical charts, analyst ratings and financial information from WSJ.Waterlase iPlus is the market’s best-selling all tissue laser. Our highest power dental laser system features enhanced capabilities such as the SureFire delivery system and REPAIR protocols on board to help you give your patients the best possible experience! More power for quick cavity preps, perio, endo, and more, all with faster healing ...Instagram:https://instagram. 1964 kennedy silver dollar worthotcmkts shmpuber stock predictionjetbluestock Apple Inc. employs 115,000 employees worldwide, with most being in the U.S. Many other jobs are attributable to Apple, including 627,000 created to support the iOS ecosystem. The company has 478 retail locations worldwide.BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software. best utility vehiclesbest airline stock to buy BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit is $26.00 , which reflects the issuance of the Series H Convertible Preferred Stock with an original issue discount. what is ninja trader BIOLASE, Inc., the World's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine.BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit was $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.